The invention provides compositions and methods for treatment of amyloidogenic
diseases. Such methods entail administering an agent that induces a beneficial
immune response against an amyloid deposit in the patient. The methods are particularly
useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such
methods, a suitable agent is A peptide or an antibody thereto.